menu

Updates on Clinical Trials in Oncology & Radiation

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Updates on Clinical Trials in Oncology & Radiation

1.25 credits
75 minutes
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Take Post-TestSkip straight to the post-test if you have already participated in this activity
Media formats available:
1.25 credits
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Two internationally known medical and radiation oncologists will discuss ongoing and recent clinical trials and offer their perspectives on how they will impact thoracic oncology practice. The panelists will also discuss current guidelines for managing patients with advanced lung cancer and emphasize the role of tissue and blood biomarkers. 

  • Course Objectives

    At the end of this webinar, the learners will be able to:

    1. Address barriers to treatment such as patient comorbidities and therapy side effects
    2. Diagnose and manage patients with advanced non-small cell lung cancer (NSCLC) according to the latest NCCN, ASCO, ASTRO, IASLC, and CHEST guidelines
    3. Explain the role of plasma-based cell-free circulating tumor DNA next generation sequencing (NGS) testing for managing advanced NSCLC at the time of diagnosis and disease progression
    4. Review the results of recent trials in medical and radiation oncology
  • Disclosure of Conflicts of Interest

    CHEST remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any relevant financial relationships that create a conflict of interest. It is not the intent of CHEST to disqualify anyone from participating in this educational activity, but to resolve any conflicts of interest that may arise from financial relationships with commercial interests. All conflicts of interest are reviewed by the educational activity course director/chair, the Education Committee, and/or the Professional Standards Committee to ensure that such situations are properly evaluated and, if necessary, resolved. CHEST educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all CHEST CME activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relevant financial relationships will be made available on-site during all educational activities.

    The following faculty members of this activity have disclosed to CHEST that they have a relevant financial relationship with a commercial interest as it relates to the activity:

    Moderator
    Septimiu Murgu, MD, FCCP
    Consultant fee, speaker bureau, advisory committee, etc.: Medtronic, Boston Scientific, Concordia/Pinnacle Biologics, Olympus, Auris Robotics

    Eric Edell, MD, FCCP
    Nothing to Disclose

    Faculty
    Narjust Duma, MD
    Consultant fee: AstraZeneca,Pfizer, NeoGenomics Labs, Janssen, BMS/Medarex, Merck, Mirati

    Andreas Rimner, MD
    Grant to Institute: Varian Medical Systems, Astrazeneca, Merck, Boehringer Ingelheim, Pfizer
    Advisory Board Member: Astrazeneca, Merck and Boehringer Ingelheim
    Consultant Fee: MoreHealth

  • Commercial Support

    We gratefully acknowledge the following for their financial support of Updates on Clinical Trials in Oncology and Radiation

    Program made possible in part by an independent educational grant from AstraZeneca Pharmaceuticals, an educational grant from Genentech, a member of the Roche Group, and an independent medical education grant from Merck Sharp & Dohme Corp.

  • CME/CE Information

    To complete the Education Activity Evaluation for Updates on Clinical Trials in Oncology and Radiation, claim CME/CE credits, and download CME/CE certificates and certificates of attendance (COA), please see the instructions below. You must complete your evaluation and download your certificate prior to the product expiration date.

    1. Log in to learning.chestnet.org using your e-mail Address and password.
    2. Find this course in your course list.
    3. Complete any post-assessment and the Education Activity Evaluation and click the Claim Credit Now link.
    4. To complete the claiming process, Click “Claim” next to the corresponding activity under “Claimable CME Activities.”
    5. Select the type of credit you want to claim, and enter the number of hours you are claiming, commensurate with your participation.
    6. Finalize by clicking the final “Claim” button.
    7. Your certificate and transcript can be viewed under “Claimed CME Activities” on your dashboard.

    If you need help, contact the CHEST Help Team at HelpTeam@chestnet.org. For faster assistance, outline the specific problem you are having, and provide your CHEST ID and contact information.

  • Accreditation and Credit Designation Statements

    Physician Credit
    The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 
    The American College of Chest Physicians designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Nursing Credit
    Provider approved by the California Board of Registered Nursing, Provider Number 16433, for 1.25 contact hours.

    Nurse Practitioners
    The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

    Physician Assistants
    American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 Category 1 credits for completing this activity.

  • Maintenance of Certification Statement

    Successful completion of this CME activity enables the participant to earn up to 1.25 MOC Part 2 Medical Knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

    Upon successful completion of this course, CHEST will submit your completion data to ABIM via ACCME's Program and Activity Reporting System (PARS) for MOC points. Please allow 3-5 businessdays after claiming for points to be reflected on your ABIM record.

  • Disclaimer

    The American College of Chest Physicians (“CHEST”) and its officers, regents, executive committee members, members, related entities, employees, representatives and other agents (collectively, “CHEST Parties”) are not responsible in any capacity for, do not warrant and expressly disclaim all liability for, any content whatsoever in any CHEST publication or other product (in any medium) and the use or reliance on any such content, all such responsibility being solely that of the authors or the advertisers, as the case may be. By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any CHEST publication or other product. Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of CHEST Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

    Copyright © 2021 by the American College of Chest Physicians.

    Copyright not claimed on material authorized by the US Government.
    All rights reserved. No part of this publication may be reproduced in any manner without permission of the publisher.

    American College of Chest Physicians
    2595 Patriot Boulevard
    Glenview, IL 60026
    Telephone: 224/521-9800; Fax: 224/521-9801
    chestnet.org

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Two internationally known medical and radiation oncologists will discuss ongoing and recent clinical trials and offer their perspectives on how they will impact thoracic oncology practice. The panelists will also discuss current guidelines for managing patients with advanced lung cancer and emphasize the role of tissue and blood biomarkers. 

  • Course Objectives

    At the end of this webinar, the learners will be able to:

    1. Address barriers to treatment such as patient comorbidities and therapy side effects
    2. Diagnose and manage patients with advanced non-small cell lung cancer (NSCLC) according to the latest NCCN, ASCO, ASTRO, IASLC, and CHEST guidelines
    3. Explain the role of plasma-based cell-free circulating tumor DNA next generation sequencing (NGS) testing for managing advanced NSCLC at the time of diagnosis and disease progression
    4. Review the results of recent trials in medical and radiation oncology
  • Disclosure of Conflicts of Interest

    CHEST remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any relevant financial relationships that create a conflict of interest. It is not the intent of CHEST to disqualify anyone from participating in this educational activity, but to resolve any conflicts of interest that may arise from financial relationships with commercial interests. All conflicts of interest are reviewed by the educational activity course director/chair, the Education Committee, and/or the Professional Standards Committee to ensure that such situations are properly evaluated and, if necessary, resolved. CHEST educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all CHEST CME activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relevant financial relationships will be made available on-site during all educational activities.

    The following faculty members of this activity have disclosed to CHEST that they have a relevant financial relationship with a commercial interest as it relates to the activity:

    Moderator
    Septimiu Murgu, MD, FCCP
    Consultant fee, speaker bureau, advisory committee, etc.: Medtronic, Boston Scientific, Concordia/Pinnacle Biologics, Olympus, Auris Robotics

    Eric Edell, MD, FCCP
    Nothing to Disclose

    Faculty
    Narjust Duma, MD
    Consultant fee: AstraZeneca,Pfizer, NeoGenomics Labs, Janssen, BMS/Medarex, Merck, Mirati

    Andreas Rimner, MD
    Grant to Institute: Varian Medical Systems, Astrazeneca, Merck, Boehringer Ingelheim, Pfizer
    Advisory Board Member: Astrazeneca, Merck and Boehringer Ingelheim
    Consultant Fee: MoreHealth

  • Commercial Support

    We gratefully acknowledge the following for their financial support of Updates on Clinical Trials in Oncology and Radiation

    Program made possible in part by an independent educational grant from AstraZeneca Pharmaceuticals, an educational grant from Genentech, a member of the Roche Group, and an independent medical education grant from Merck Sharp & Dohme Corp.

  • CME/CE Information

    To complete the Education Activity Evaluation for Updates on Clinical Trials in Oncology and Radiation, claim CME/CE credits, and download CME/CE certificates and certificates of attendance (COA), please see the instructions below. You must complete your evaluation and download your certificate prior to the product expiration date.

    1. Log in to learning.chestnet.org using your e-mail Address and password.
    2. Find this course in your course list.
    3. Complete any post-assessment and the Education Activity Evaluation and click the Claim Credit Now link.
    4. To complete the claiming process, Click “Claim” next to the corresponding activity under “Claimable CME Activities.”
    5. Select the type of credit you want to claim, and enter the number of hours you are claiming, commensurate with your participation.
    6. Finalize by clicking the final “Claim” button.
    7. Your certificate and transcript can be viewed under “Claimed CME Activities” on your dashboard.

    If you need help, contact the CHEST Help Team at HelpTeam@chestnet.org. For faster assistance, outline the specific problem you are having, and provide your CHEST ID and contact information.

  • Accreditation and Credit Designation Statements

    Physician Credit
    The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 
    The American College of Chest Physicians designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Nursing Credit
    Provider approved by the California Board of Registered Nursing, Provider Number 16433, for 1.25 contact hours.

    Nurse Practitioners
    The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

    Physician Assistants
    American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 Category 1 credits for completing this activity.

  • Maintenance of Certification Statement

    Successful completion of this CME activity enables the participant to earn up to 1.25 MOC Part 2 Medical Knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

    Upon successful completion of this course, CHEST will submit your completion data to ABIM via ACCME's Program and Activity Reporting System (PARS) for MOC points. Please allow 3-5 businessdays after claiming for points to be reflected on your ABIM record.

  • Disclaimer

    The American College of Chest Physicians (“CHEST”) and its officers, regents, executive committee members, members, related entities, employees, representatives and other agents (collectively, “CHEST Parties”) are not responsible in any capacity for, do not warrant and expressly disclaim all liability for, any content whatsoever in any CHEST publication or other product (in any medium) and the use or reliance on any such content, all such responsibility being solely that of the authors or the advertisers, as the case may be. By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any CHEST publication or other product. Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of CHEST Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

    Copyright © 2021 by the American College of Chest Physicians.

    Copyright not claimed on material authorized by the US Government.
    All rights reserved. No part of this publication may be reproduced in any manner without permission of the publisher.

    American College of Chest Physicians
    2595 Patriot Boulevard
    Glenview, IL 60026
    Telephone: 224/521-9800; Fax: 224/521-9801
    chestnet.org

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule16 Aug 2022
Webpack App